{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:06:46Z","timestamp":1792836406843,"version":"4.5.0"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-2018-159590"],"award-info":[{"award-number":["PJT-2018-159590"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes prevalence is increasing worldwide, and epidemiological studies report an association between diabetes incidence and environmental pollutant exposure. There are &amp;gt;84,000 chemicals in commerce, many of which are released into the environment without a clear understanding of potential adverse health consequences. While <jats:italic>in vivo<\/jats:italic> rodent studies remain an important tool for testing chemical toxicity systemically, we urgently need high-throughput screening platforms in biologically relevant models to efficiently prioritize chemicals for in depth toxicity analysis. Given the increasing global burden of obesity and diabetes, identifying chemicals that disrupt metabolism should be a high priority. Pancreatic endocrine cells are key regulators of systemic metabolism, yet often overlooked as a target tissue in toxicology studies. Immortalized \u03b2-cell lines and primary human, porcine, and rodent islets are widely used for studying the endocrine pancreas <jats:italic>in vitro<\/jats:italic>, but each have important limitations in terms of scalability, lifespan, and\/or biological relevance. Human pluripotent stem cell (hPSC) culture is a powerful tool for <jats:italic>in vitro<\/jats:italic> toxicity testing that addresses many of the limitations with other \u03b2-cell models. Current <jats:italic>in vitro<\/jats:italic> differentiation protocols can efficiently generate glucose-responsive insulin-secreting \u03b2-like cells that are not fully mature, but still valuable for high-throughput toxicity screening <jats:italic>in vitro<\/jats:italic>. Furthermore, hPSCs can be applied as a model of developing pancreatic endocrine cells to screen for chemicals that influence endocrine cell formation during critical windows of differentiation. Given their versatility, we recommend using hPSCs to identify potential \u03b2-cell toxins, which can then be prioritized as chemicals of concern for metabolic disruption.<\/jats:p>","DOI":"10.3389\/fendo.2020.604998","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:48:10Z","timestamp":1611031690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Human Pluripotent Stem Cells: A Unique Tool for Toxicity Testing in Pancreatic Progenitor and Endocrine Cells"],"prefix":"10.3389","volume":"11","author":[{"given":"Erin M.","family":"MacFarlane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"B1","volume-title":"IDF Diabetes Atlas","year":"2019"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183754","article-title":"Regulation of insulin secretion in human pancreatic islets","volume":"75","author":"Rorsman","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"316ps23","DOI":"10.1126\/scitranslmed.aaa9359","article-title":"Replacing and safeguarding pancreatic beta cells for diabetes","volume":"7","author":"Bruin","year":"2015","journal-title":"Sci Transl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality","volume":"52","author":"Kahn","year":"2009","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis","volume":"6","author":"Chen","year":"2017","journal-title":"Mol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3437","article-title":"Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci","volume":"47","author":"Gaulton","year":"2015","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2897","article-title":"Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility","volume":"46","year":"2014","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaf5094","article-title":"Exposing the exposures responsible for type 2 diabetes and obesity","volume":"354","author":"Franks","year":"2016","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/456018a","article-title":"Personal genomes: The case of the missing heritability","volume":"456","author":"Maher","year":"2008","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.11.1031","article-title":"Health effects of dioxin exposure: a 20-year mortality study","volume":"153","author":"Bertazzi","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2449","article-title":"Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort","volume":"31","author":"Wang","year":"2008","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.98106645","article-title":"Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers","volume":"106","author":"Vena","year":"1998","journal-title":"Environ Health Perspect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/oem.56.4.270","article-title":"Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"56","author":"Calvert","year":"1999","journal-title":"Occup Environ Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.envres.2014.04.027","article-title":"Agent Orange exposure and disease prevalence in Korean Vietnam veterans: the Korean veterans health study","volume":"133","author":"Yi","year":"2014","journal-title":"Environ Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.41.149","article-title":"Impact of Agent Orange exposure among Korean Vietnam veterans","volume":"41","author":"Kim","year":"2003","journal-title":"Ind Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199705000-00005","article-title":"Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand","volume":"8","author":"Henriksen","year":"1997","journal-title":"Epidemiology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200001000-00010","article-title":"Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure","volume":"11","author":"Longnecker","year":"2000","journal-title":"Epidemiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0432-6","article-title":"Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence","volume":"13","author":"Kuo","year":"2013","journal-title":"Curr Diabetes Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69174-5","article-title":"Persistent organic pollutants and the burden of diabetes","volume":"368","author":"Porta","year":"2006","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1104597","article-title":"Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review","volume":"120","author":"Thayer","year":"2012","journal-title":"Environ Health Perspect"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0543","article-title":"A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002","volume":"29","author":"Lee","year":"2006","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.diabet.2013.01.006","article-title":"The association of type 2 diabetes and insulin resistance\/secretion with persistent organic pollutants in two First Nations communities in northern Ontario","volume":"39","author":"Pal","year":"2013","journal-title":"Diabetes Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2006.11.002","article-title":"3rd. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey","volume":"103","author":"Everett","year":"2007","journal-title":"Environ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1210\/er.2013-1084","article-title":"Chlorinated persistent organic pollutants, obesity, and type 2 diabetes","volume":"35","author":"Lee","year":"2014","journal-title":"Endocr Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1205502","article-title":"Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review","volume":"121","author":"Taylor","year":"2013","journal-title":"Environ Health Perspect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0674-z","article-title":"Serum aryl hydrocarbon receptor ligand activity is associated with insulin resistance and resulting type 2 diabetes","volume":"52","author":"Roh","year":"2015","journal-title":"Acta Diabetol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2329","article-title":"Exposure to persistent organic pollutants: relationship with abnormal glucose metabolism and visceral adiposity","volume":"37","author":"Dirinck","year":"2014","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1066-0","article-title":"A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit","volume":"51","author":"Jorgensen","year":"2008","journal-title":"Diabetologia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0188","article-title":"Low-Dose Persistent Organic Pollutants Impair Insulin Secretory Function of Pancreatic beta-Cells: Human and In Vitro Evidence","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"key":"B31","volume-title":"The Canadian Environmental Protection Act, 1999","year":"1999"},{"key":"B32","article-title":"Toxic substances: EPA has increased efforts to assess and control chemicals but could strengthen its approach. GAO-13-249","year":"2013"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2011.08.007","article-title":"Endocrine disrupting chemicals and disease susceptibility","volume":"127","author":"Schug","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/tx500014w","article-title":"Chemical properties, environmental fate, and degradation of seven classes of pollutants","volume":"27","author":"Manzetti","year":"2014","journal-title":"Chem Res Toxicol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/44517","article-title":"Exposure to bisphenol A advances puberty","volume":"401","author":"Howdeshell","year":"1999","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes8090229","article-title":"Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer","volume":"8","author":"Lecomte","year":"2017","journal-title":"Genes (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1097\/MD.0000000000000211","article-title":"and hormone-associated cancers: current progress and perspectives","volume":"94","author":"Gao","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.51","article-title":"Endocrine-disrupting chemicals and the regulation of energy balance","volume":"13","author":"Nadal","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2012.241","article-title":"Exposure to environmental endocrine disruptors and child development","volume":"166","author":"Meeker","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an Endocrine Society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s40572-017-0137-0","article-title":"Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals","volume":"4","author":"Mimoto","year":"2017","journal-title":"Curr Environ Health Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod Toxicol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00033","article-title":"Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health","volume":"10","author":"Sargis","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fenvs.2018.00079","article-title":"Remediation of Polychlorinated Biphenyls (PCBs) in Contaminated Soils and Sediment: State of Knowledge and Perspectives","volume":"6","author":"Jing","year":"2018","journal-title":"Front Environ Sci"},{"key":"B45","article-title":"Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables Volume 1 and 2","year":"2019"},{"key":"B46","article-title":"Uses of human biomonitoring in data risk assessment","year":"2018"},{"key":"B47","article-title":"National biomonitoring program","year":"2017"},{"key":"B48","first-page":"44","article-title":"Synopsis of Research conducted under the 2005\u20132006 Northern Contaminants Program Indian and Northern Affairs Canada","author":"Dewailly","year":"2006"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-015-5225-9","article-title":"Persistent organic pollutants (POPs): a global issue, a global challenge","volume":"24","author":"Ashraf","year":"2017","journal-title":"Environ Sci Pollut Res Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0901716","article-title":"Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A","volume":"118","author":"Vandenberg","year":"2010","journal-title":"Environ Health Perspect"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2008.0268","article-title":"Phthalates and other additives in plastics: human exposure and associated health outcomes","volume":"364","author":"Meeker","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.8075","article-title":"Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age","volume":"114","author":"Main","year":"2006","journal-title":"Environ Health Perspect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12940-015-0029-4","article-title":"Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity","volume":"14","author":"Zoeller","year":"2015","journal-title":"Environ Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01809.x","article-title":"The origins of the developmental origins theory","volume":"261","author":"Barker","year":"2007","journal-title":"J Intern Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000360506","article-title":"Developmental programming and transgenerational transmission of obesity","volume":"64","author":"Vickers","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/BF00399095","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth","volume":"36","author":"Barker","year":"1993","journal-title":"Diabetologia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0459-1","article-title":"Patterns of growth among children who later develop type 2 diabetes or its risk factors","volume":"49","author":"Eriksson","year":"2006","journal-title":"Diabetologia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.5104","article-title":"Association of Maternal Exposure to Persistent Organic Pollutants in Early Pregnancy With Fetal Growth","volume":"174","author":"Ouidir","year":"2019","journal-title":"JAMA Pediatr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00112","article-title":"Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease","volume":"10","author":"Papalou","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eep\/dvv013","article-title":"In utero exposures to environmental organic pollutants disrupt epigenetic marks linked to fetoplacental development","volume":"2","author":"Kappil","year":"2016","journal-title":"Environ Epigenet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-013-0328-8","article-title":"Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals","volume":"18","author":"Inadera","year":"2013","journal-title":"Environ Health Prev Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.envint.2016.04.040","article-title":"Perinatal exposure to dioxins and dioxin-like compounds and infant growth and body mass index at seven years: A pooled analysis of three European birth cohorts","volume":"94","author":"Iszatt","year":"2016","journal-title":"Environ Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00937.x","article-title":"Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years","volume":"97","author":"Smink","year":"2008","journal-title":"Acta Paediatr"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2008.041921","article-title":"Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring","volume":"66","author":"Karmaus","year":"2009","journal-title":"Occup Environ Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.0800003","article-title":"Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life","volume":"117","author":"Verhulst","year":"2009","journal-title":"Environ Health Perspect"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2016.12.015","article-title":"Identification of chemical mixtures to which Canadian pregnant women are exposed: The MIREC Study","volume":"99","author":"Lee","year":"2017","journal-title":"Environ Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2017.03.157","article-title":"Dioxins\/furans and PCBs in Canadian human milk: 2008-2011","volume":"595","author":"Rawn","year":"2017","journal-title":"Sci Total Environ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12940-016-0143-y","article-title":"Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study","volume":"15","author":"Fisher","year":"2016","journal-title":"Environ Health"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12061","article-title":"Cohort profile: the maternal-infant research on environmental chemicals research platform","volume":"27","author":"Arbuckle","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00766","article-title":"Metabolism Disrupting Chemicals and Alteration of Neuroendocrine Circuits Controlling Food Intake and Energy Metabolism","volume":"9","author":"Marraudino","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/taap.1995.1025","article-title":"Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice","volume":"130","author":"Diliberto","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05035-0","article-title":"Functional cytochrome P450 1a enzymes are induced in mouse and human islets following pollutant exposure","volume":"63","author":"Ibrahim","year":"2020","journal-title":"Diabetologia"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2020.101104","article-title":"Female mice exposed to low doses of dioxin during pregnancy and lactation have increased susceptibility to diet-induced obesity and diabetes","volume":"101104","author":"Hoyeck","year":"2020","journal-title":"Mol Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e31109","DOI":"10.1371\/journal.pone.0031109","article-title":"Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta","volume":"7","author":"Soriano","year":"2012","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","first-page":"11770","DOI":"10.1038\/s41598-017-11995-3","article-title":"Molecular mechanisms involved in the non-monotonic effect of bisphenol-a on ca2+ entry in mouse pancreatic beta-cells","volume":"7","author":"Villar-Pazos","year":"2017","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"129051","DOI":"10.1016\/j.chemosphere.2020.129051","article-title":"Bisphenol-S and Bisphenol-F alter mouse pancreatic \u03b2-cell ion channel expression and activity and insulin release through an estrogen receptor ER\u03b2 mediated pathway","author":"Martinez-Pinna","year":"2020","journal-title":"Chemosphere"},{"key":"B78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tox.2015.06.001","article-title":"A Northern contaminant mixture impairs pancreas function in obese and lean JCR rats and inhibits insulin secretion in MIN6 cells","volume":"334","author":"Mailloux","year":"2015","journal-title":"Toxicology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2004.12.004","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets","volume":"156","author":"Novelli","year":"2005","journal-title":"Toxicol Lett"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1459","article-title":"Aryl hydrocarbon receptor-mediated effects of TCDD on glucose-stimulated insulin secretion in mice","volume":"29","author":"Kurita","year":"2009","journal-title":"J Appl Toxicol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41598-020-57973-0","article-title":"Long-term metabolic consequences of acute dioxin exposure differ between male and female mice","volume":"10","author":"Hoyeck","year":"2020","journal-title":"Sci Reports"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.12.294587","article-title":"Chronic low-dose dioxin exposure accelerates high fat diet-induced hyperglycemia in female mice","author":"Matteo","year":"2020","journal-title":"BioRxiv"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1101\/534669","article-title":"A glucose-dependent spatial patterning of exocytosis in human beta-cells is disrupted in type 2 diabetes","volume":"5","author":"Fu","year":"2019","journal-title":"JCI Insight"},{"key":"B84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mam.2014.12.002","article-title":"Natural history of beta-cell adaptation and failure in type 2\u00a0diabetes","volume":"42","author":"Alejandro","year":"2015","journal-title":"Mol Aspects Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cmet.2020.04.005","article-title":"Patch-Seq Links Single-Cell Transcriptomes to Human Islet Dysfunction in Diabetes","volume":"31","author":"Camunas-Soler","year":"2020","journal-title":"Cell Metab"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.727","article-title":"Functional and molecular defects of pancreatic islets in human type 2 diabetes","volume":"54","author":"Del Guerra","year":"2005","journal-title":"Diabetes"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0150","article-title":"Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin","volume":"89","author":"Marchetti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2016.09.001","article-title":"Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes","volume":"179","author":"Scott","year":"2017","journal-title":"Transl Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1911","article-title":"Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro: Results From the DiViD Study","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0674","article-title":"Reduced beta-cell function in early preclinical type 1 diabetes","volume":"174","author":"Koskinen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0981-8","article-title":"First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes","volume":"45","author":"Keskinen","year":"2002","journal-title":"Diabetologia"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111274","article-title":"First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes","volume":"138","author":"Chase","year":"2001","journal-title":"J Pediatr"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3676-7","article-title":"Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity","volume":"58","author":"Templeman","year":"2015","journal-title":"Diabetologia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0449","article-title":"A causal role for hyperinsulinemia in obesity","volume":"232","author":"Templeman","year":"2017","journal-title":"J Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J Endocr Soc"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.10.019","article-title":"Hyperinsulinemia drives diet-induced obesity independently of brain insulin production","volume":"16","author":"Mehran","year":"2012","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020735","article-title":"Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea","volume":"88","author":"Yoon","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-1277","article-title":"{beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes","volume":"151","author":"Hanley","year":"2010","journal-title":"Endocrinology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3945\/an.113.005488","article-title":"Pancreatic beta-cell proliferation in obesity","volume":"5","author":"Linnemann","year":"2014","journal-title":"Adv Nutr"},{"key":"B100","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/dom.12729","article-title":"Mechanisms of beta-cell functional adaptation to changes in workload","volume":"18","author":"Wortham","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1834","article-title":"Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes","volume":"30","author":"Cnop","year":"2007","journal-title":"Diabetes Care"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nature05537","article-title":"Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver","volume":"445","author":"Stanger","year":"2007","journal-title":"Nature"},{"key":"B104","first-page":"79","article-title":"Developmental programming of the pancreatic islet by in utero overnutrition","volume":"10","author":"Elsakr","year":"2017","journal-title":"Trends Dev Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/C2TX20051A","article-title":"In vitro models for liver toxicity testing","volume":"2","author":"Soldatow","year":"2013","journal-title":"Toxicol Res (Camb)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul Toxicol Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.41.2.114","article-title":"Humane endpoints and acute toxicity testing","volume":"41","author":"Sass","year":"2000","journal-title":"ILAR J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1206","article-title":"Formation of a human beta-cell population within pancreatic islets is set early in life","volume":"97","author":"Gregg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401058","article-title":"Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets","volume":"36","author":"Ishihara","year":"1993","journal-title":"Diabetologia"},{"key":"B111","first-page":"7","article-title":"Insulin-secreting cell lines: classification, characteristics and potential applications","volume":"22","author":"Poitout","year":"1996","journal-title":"Diabetes Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1099","article-title":"Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells","volume":"145","author":"Merglen","year":"2004","journal-title":"Endocrinology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e60030","DOI":"10.1371\/journal.pone.0060030","article-title":"Evaluation of the INS-1 832\/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function","volume":"8","author":"Hectors","year":"2013","journal-title":"PLoS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.12.007","article-title":"The EndoC-betaH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates","volume":"8","author":"Tsonkova","year":"2018","journal-title":"Mol Metab"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0120879","DOI":"10.1371\/journal.pone.0120879","article-title":"Characterization of stimulus-secretion coupling in the human pancreatic EndoC-betaH1 beta cell line","volume":"10","author":"Andersson","year":"2015","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58447","article-title":"A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion","volume":"121","author":"Ravassard","year":"2011","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00544.2014","article-title":"Distinct differences in the responses of the human pancreatic beta-cell line EndoC-betaH1 and human islets to proinflammatory cytokines","volume":"309","author":"Oleson","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm7030054","article-title":"The Cells of the Islets of Langerhans","volume":"7","author":"Da Silva Xavier","year":"2018","journal-title":"J Clin Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4772-2","article-title":"Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions","volume":"62","author":"Hart","year":"2019","journal-title":"Diabetologia"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dev.186213","article-title":"Molecular and genetic regulation of pig pancreatic islet cell development","volume":"147","author":"Kim","year":"2020","journal-title":"Development"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e0216254","DOI":"10.1371\/journal.pone.0216254","article-title":"Distributions of endocrine cell clusters during porcine pancreatic development","volume":"14","author":"Nagaya","year":"2019","journal-title":"PLoS One"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2014.00007","article-title":"Pig-islet xenotransplantation: recent progress and current perspectives","volume":"1","author":"Zhu","year":"2014","journal-title":"Front Surg"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X662372","article-title":"In vitro maturation of viable islets from partially digested young pig pancreas","volume":"23","author":"Lamb","year":"2014","journal-title":"Cell Transpl"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1210\/en.2001-211344","article-title":"Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin","volume":"143","author":"Hardikar","year":"2002","journal-title":"Endocrinology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/labinvest.2016.123","article-title":"An optimized protocol for purification of functional islets of Langerhans","volume":"97","author":"Saliba","year":"2017","journal-title":"Lab Invest"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3844","article-title":"Facile mechanical shaking method is an improved isolation approach for islet preparation and transplantation","volume":"12","author":"Yin","year":"2016","journal-title":"Exp Ther Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12575-009-9021-0","article-title":"A practical guide to rodent islet isolation and assessment","volume":"11","author":"Carter","year":"2009","journal-title":"Biol Proced Online"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1562","article-title":"Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore","volume":"157","author":"Lyon","year":"2016","journal-title":"Endocrinology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4876-3","article-title":"The\u00a0Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles","volume":"62","author":"Brissova","year":"2019","journal-title":"Diabetologia"},{"key":"B130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.matbio.2018.03.018","article-title":"Culturing functional pancreatic islets on alpha5-laminins and curative transplantation to diabetic mice","volume":"70","author":"Sigmundsson","year":"2018","journal-title":"Matrix Biol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3727\/096368916X692834","article-title":"Effect of Manufacturing Procedures on Human Islet Isolation From Donor Pancreata Standardized by the North American Islet Donor Score","volume":"26","author":"Yeh","year":"2017","journal-title":"Cell Transpl"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1333","article-title":"Effect of donor age on function of isolated human islets","volume":"55","author":"Ihm","year":"2006","journal-title":"Diabetes"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X662417","article-title":"Systematic analysis of donor and isolation factor\u2019s impact on human islet yield and size distribution","volume":"22","author":"Wang","year":"2013","journal-title":"Cell Transpl"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of Dynamic Function in Human Stem Cell-Derived beta Cells","volume":"12","author":"Velazco-Cruz","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0430-6","article-title":"Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells","volume":"38","author":"Hogrebe","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic beta cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201591058","article-title":"Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro","volume":"34","author":"Russ","year":"2015","journal-title":"EMBO J"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1168-5","article-title":"Charting cellular identity during human in vitro beta-cell differentiation","volume":"569","author":"Veres","year":"2019","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1038\/s41467-018-07201-1","article-title":"Chen S. A hPSC-based platform to discover gene-environment interactions that impact human beta-cell and dopamine neuron survival","volume":"9","author":"Zhou","year":"2018","journal-title":"Nat Commun"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e114275","DOI":"10.1371\/journal.pone.0114275","article-title":"TALEN\/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm","volume":"9","author":"Krentz","year":"2014","journal-title":"PLoS One"},{"key":"B142","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.devcel.2017.02.006","article-title":"Phosphorylation of NEUROG3 Links Endocrine Differentiation to the Cell Cycle in Pancreatic Progenitors","volume":"41","author":"Krentz","year":"2017","journal-title":"Dev Cell"},{"key":"B143","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s00125-011-2379-y","article-title":"INS(GFP\/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells","volume":"55","author":"Micallef","year":"2012","journal-title":"Diabetologia"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.11.008","article-title":"Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors","volume":"11","author":"Krentz","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.033","article-title":"Differentiation of cardiomyocytes and generation of human engineered heart tissue","volume":"12","author":"Breckwoldt","year":"2017","journal-title":"Nat Protoc"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e53764","DOI":"10.1371\/journal.pone.0053764","article-title":"Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.273144","article-title":"Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method","volume":"111","author":"Zhang","year":"2012","journal-title":"Circ Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.10.014","article-title":"Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform","volume":"1863","author":"Denning","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e37004","DOI":"10.1371\/journal.pone.0037004","article-title":"A scalable system for production of functional pancreatic progenitors from human embryonic stem cells","volume":"7","author":"Schulz","year":"2012","journal-title":"PLoS One"},{"key":"B150","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tcb.2017.09.006","article-title":"Humanity in a Dish: Population Genetics with iPSCs","volume":"28","author":"Warren","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4908-z","article-title":"Genome editing of human pancreatic beta cell models: problems, possibilities and outlook","volume":"62","author":"Balboa","year":"2019","journal-title":"Diabetologia"},{"key":"B152","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/stem.2913","article-title":"Concise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic beta-Cell Pathology","volume":"37","author":"Balboa","year":"2019","journal-title":"Stem Cells"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C112.428979","article-title":"Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young","volume":"288","author":"Teo","year":"2013","journal-title":"J Biol Chem"},{"key":"B154","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.scr.2018.06.013","article-title":"Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs","volume":"31","author":"Braverman-Gross","year":"2018","journal-title":"Stem Cell Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38519","article-title":"Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes","volume":"7","author":"Balboa","year":"2018","journal-title":"Elife"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0717","article-title":"beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome","volume":"63","author":"Shang","year":"2014","journal-title":"Diabetes"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2016.01.007","article-title":"Early Developmental Perturbations in a Human Stem Cell Model of MODY5\/HNF1B Pancreatic Hypoplasia","volume":"6","author":"Teo","year":"2016","journal-title":"Stem Cell Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12727","article-title":"Insulin-producing cells derived from \u2018induced pluripotent stem cells\u2019 of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes","volume":"9","author":"Hosokawa","year":"2017","journal-title":"J Diabetes Investig"},{"key":"B159","doi-asserted-by":"publisher","first-page":"107894","DOI":"10.1016\/j.celrep.2020.107894","article-title":"Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells","volume":"32","author":"Leite","year":"2020","journal-title":"Cell Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1038\/ncomms11463","article-title":"Generation of stem cell-derived beta-cells from patients with type 1 diabetes","volume":"7","author":"Millman","year":"2016","journal-title":"Nat Commun"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.8682.1","article-title":"Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology","volume":"5","author":"Beer","year":"2016","journal-title":"F1000Res"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.03.015","article-title":"Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes","volume":"18","author":"Zhu","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1412","article-title":"The Basic Helix-Loop-Helix Transcription Factor NEUROG3 Is Required for Development of the Human Endocrine Pancreas","volume":"64","author":"McGrath","year":"2015","journal-title":"Diabetes"},{"key":"B164","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1038\/s41598-017-03349-w","article-title":"Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR\/Cas9","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2017.07.124","article-title":"Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury","volume":"65","author":"Goldring","year":"2017","journal-title":"Hepatology"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170780","article-title":"Stem cell models as an in vitro model for predictive toxicology","volume":"476","author":"Lynch","year":"2019","journal-title":"Biochem J"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2015.659","article-title":"High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes","volume":"13","author":"Grimm","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.008409","article-title":"Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture","volume":"5","author":"Lahti","year":"2012","journal-title":"Dis Model Mech"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr073","article-title":"Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation","volume":"32","author":"Matsa","year":"2011","journal-title":"Eur Heart J"},{"key":"B171","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jacc.2012.02.066","article-title":"Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells","volume":"60","author":"Itzhaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.09.017","article-title":"Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity","volume":"273","author":"Sirenko","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3832","article-title":"High-efficiency cellular reprogramming with microfluidics","volume":"13","author":"Luni","year":"2016","journal-title":"Nat Methods"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.604998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:48:14Z","timestamp":1611031694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.604998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":173,"alternative-id":["10.3389\/fendo.2020.604998"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.604998","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"article-number":"604998"}}